Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies

Autoimmunity Reviews

Volumn 9, Issue 1, 2009, Pages 58-61

  Rönnelid, Johan ^a,b   Barbasso Helmers, Sevim ^b   Storfors, Helena ^a   Grip, Katarina ^a   Rönnblom, Lars ^c   Franck Larsson, Karin ^c   Nordmark, Gunnel ^c   Lundberg, Ingrid E ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoantibodies; Dermatomyositis; Diagnosis; Polymyositis

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; JO 1 ANTIBODY; JO 1 ANTIGEN; KU ANTIGEN; MI 2 ANTIBODY; MI 2 ANTIGEN; PI 12 ANTIGEN; PI 7 ANTIBODY; PI 7 ANTIGEN; PM SCL ANTIBODY; PM SCL ANTIGEN; RO 52 ANTIGEN; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MYOSITIS; POLYMYOSITIS; REVIEW; SCREENING; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOSITIS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 69649105402     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.03.005     Document Type: Review

References (26)

1. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325 (1991) 1487-1498
2. Arnett F.C., Targoff I.N., Mimori T., Goldstein R., Warner N.B., and Reveille J.D. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 39 (1996) 1507-1518
3. Shamim E.A., Rider L.G., and Miller F.W. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 12 (2000) 482-491
4. Reichlin M., and Arnett Jr. F.C. Multiplicity of antibodies in myositis sera. Arthritis Rheum 27 (1984) 1150-1156
5. Brouwer R., Hengstman G.J., Vree Egberts W., Ehrfeld H., Bozic B., Ghirardello A., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60 (2001) 116-123
6. Barbasso Helmers S. The role of autoantibodies in inflammatory myopathies (2007), Karolinska Institutet, Stockholm. 978-91-7357-312-2
7. Eloranta M.L., Barbasso Helmers S., Ulfgren A.K., Rönnblom L., Alm G.V., and Lundberg I.E. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum 56 (2007) 3112-3124
8. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 (1975) 344-347
9. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292 (1975) 403-407
10. Griggs R.C., Askanas V., DiMauro S., Engel A., Karpati G., Mendell J.R., et al. Inclusion body myositis and myopathies. Ann Neurol 38 (1995) 705-713
11. Love L.A., Leff R.L., Fraser D.D., Targoff I.N., Dalakas M., Plotz P.H., et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70 (1991) 360-374
12. Hengstman G.J., Vree Egberts W.T., Seelig H.P., Lundberg I.E., Moutsopoulos H.M., Doria A., et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis 65 (2006) 242-245
13. Hengstman G.J., ter Laak H.J., Vree Egberts W.T., Lundberg I.E., Moutsopoulos H.M., Vencovsky J., et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65 (2006) 1635-1638
14. Ghirardello A., Zampieri S., Tarricone E., Iaccarino L., Bendo R., Briani C., et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39 (2006) 217-221
15. Selva-O'Callaghan A., Labrador-Horrillo M., Solans-Laque R., Simeon-Aznar C.P., Martinez-Gomez X., and Vilardell-Tarres M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55 (2006) 791-798
16. Targoff I.N., Mamyrova G., Trieu E.P., Perurena O., Koneru B., O'Hanlon T.P., et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54 (2006) 3682-3689
17. Betteridge Z., Gunawardena H., North J., Slinn J., and McHugh N. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford) 46 (2007) 1005-1008
18. Betteridge Z., Gunawardena H., North J., Slinn J., and McHugh N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum 56 (2007) 3132-3137
19. Mahler M., and Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev 6 (2007) 432-437
20. Raijmakers R., Renz M., Wiemann C., Egberts W.V., Seelig H.P., van Venrooij W.J., et al. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum 50 (2004) 565-569
21. Espinosa A., Zhou W., Ek M., Hedlund M., Brauner S., Popovic K., et al. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 176 (2006) 6277-6285
22. Rutjes S.A., Vree Egberts W.T., Jongen P., Van Den Hoogen F., Pruijn G.J., and Van Venrooij W.J. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109 (1997) 32-40
23. Greidinger E.L., Zang Y., Martinez L., Jaimes K., Nassiri M., Bejarano P., et al. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum 56 (2007) 1589-1597
24. Briani C., Doria A., Sarzi-Puttini P., and Dalakas M.C. Update on idiopathic inflammatory myopathies. Autoimmunity 39 (2006) 161-170
25. Kubo M., Ihn H., Yazawa N., Sato S., Kikuchi K., and Tamaki K. Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis. J Invest Dermatol 112 (1999) 711-715
26. Aloush V., Litinsky I., Caspi D., and Elkayam O. Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum 36 (2006) 4-9